uniQure is a Netherlands-based biotechnology company developing gene therapies for serious genetic diseases such as hemophilia and Huntington's disease.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Irenic Capital | 48 | New buy | 100,000 | $1,635,000 | 0.1% |
| Louis Bacon / Moore | 56 | Added +63% | 122,222 | $1,998,330 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.